Ignite Creation Date:
2025-12-26 @ 11:49 AM
Ignite Modification Date:
2026-03-11 @ 5:31 PM
Study NCT ID:
NCT00324116
Status:
COMPLETED
Last Update Posted:
2010-03-23
First Post:
2006-05-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluation Of Safety And Efficacy Of 0.3 Mg/Eye Macugen In Patients With Small Age-Related Macular Degeneration Lesions
Sponsor:
Pfizer
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
A5751016
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Director, Clinical Trial Disclosure Group
Old Organization:
Pfizer Inc
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |